Document Detail

Rhodium-catalysed conjugate addition of arylboronic acids to enantiopure dehydroamino acid derivatives.
MedLine Citation:
PMID:  20835454     Owner:  NLM     Status:  In-Process    
The rhodium-catalysed conjugate addition of arylboronic acids to an enantiopure acceptor derived from (R)-S-methylcysteine proceeds under substrate control to provide a range of functionalised phenylalanine derivatives with excellent stereocontrol via a highly diastereoselective protonation.
Jonathan D Hargrave; Gerwyn Bish; Gabriele Kociok Köhn; Christopher G Frost
Related Documents :
10642054 - Comparative chemical evaluation of two commercially available derivatives of hyaluronic...
12036034 - Formal total synthesis of (+)-macrosphelide a based on regioselective hydrolysis using ...
8264244 - Deriving an amino acid distance matrix.
22121364 - Suitability of commercial transport media for biological pathogens under nonideal condi...
12019764 - Gluconic acid production by aspergillus niger mutant ors-4.410 in submerged and solid s...
18079054 - Integrated bacterial process for the treatment of a spent nickel catalyst.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-08
Journal Detail:
Title:  Organic & biomolecular chemistry     Volume:  8     ISSN:  1477-0539     ISO Abbreviation:  Org. Biomol. Chem.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101154995     Medline TA:  Org Biomol Chem     Country:  England    
Other Details:
Languages:  eng     Pagination:  5120-5     Citation Subset:  IM    
Department of Chemistry, University of Bath, Claverton Down, Bath, UKBA2 7AY.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Naturally occurring circular proteins: distribution, biosynthesis and evolution.
Next Document:  Novel dialkoxytriazine-type glycosyl donors for cellulase-catalysed lactosylation.